Expanded Access Study Of BEXXAR® For Low Grade And Transformed Low-Grade Non-Hodgkin's Lymphoma

Expanded access is no longer available for this treatment.

Study NCT00268203 Information provided by GlaxoSmithKline

First Received: December 20, 2005 Last Updated: July 16, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	Expanded access is no longer available for this treatment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given